6446 — PHARMAESSENTIA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for PHARMAESSENTIA, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	657	2,882	5,106	9,735	15,635
Cost of Revenue
Gross Profit	278	2,070	4,495	8,558	13,950
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	3,464	4,910	7,019	7,999	10,707
Operating Profit	-2,808	-2,028	-1,913	1,736	4,928
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2,796	-1,842	-987	2,995	4,983
Provision for Income Taxes
Net Income After Taxes	-2,796	-1,375	-624	2,966	5,045
Minority Interest
Net Income Before Extraordinary Items
Net Income	-2,796	-1,375	-624	2,966	5,045
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-2,796	-1,375	-624	2,966	5,045
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-9.58	-4.36	-1.74	8	13.6
Dividends per Share